Our findings suggest that bile reflux can promote gastric carcinogenesis through the activation of the IL‐6/JAK1/STAT3 pro‐inflammatory signaling pathway and that STAT3 inhibition can alleviate this carcinogenic effect, thus providing an alternative strategy for the prevention of gastric cancer associated with bile reflux. Here, JAK1 is linked to bile reflux.